Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32463475!ä!32463475 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lakartidningen 2020 ; 117 (ä): ä Nephropedia Template TP {{tp|p=32463475|t=2020. Snabbtest for covid-19-antikroppar bor utforas av utbildad personal |pdf=|usr=}}{{32463475}} gab.com Text Snabbtest for covid-19-antikroppar bor utforas av utbildad personal JO: Lakartidningen http://www.kidney.de/pget.php?&tw=1&pmid=32463475 #FOAvip Increasing evidence indicates immunity against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) after covid-19, but it remains unclear for how long the protection remains. Serology testing seems to have a higher sensitivity than molecular diagnostics from 8 days after onset of symtoms, and should be part of risk assessment and epidemiological studies of COVID-19. The performance of commercial serological point-of-care (POC) lateral flow tests are highly manufacturer-dependant. Low sensitivity increases the risk of false negative results and could result in unnecessary quarantine of test persons with developed antibodies. Low specificity increases the risk of false positive results and could lead to false assumptions of immunity. Carefully selected serological POC tests for sars-cov-2 can be used in large scale testing but should only be used by licensed medical staff able to understand their limitations and interpret the results. Twit Text FOAVip Snabbtest for covid-19-antikroppar bor utforas av utbildad personal ????Lakartidningen http://www.kidney.de/pget.php?&tw=1&pmid=32463475 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32463475 #FOAvip English Wikipedia <ref>{{Cite pmid|32463475}}</ref> Snabbtest for covid-19-antikroppar bor utforas av utbildad personal #MMPMID32463475 Stackelberg O; Esmaeilzadeh M; Olsen B; Lundkvist A Lakartidningen 2020[May]; 117 (ä): ä PMID32463475show ga Increasing evidence indicates immunity against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) after covid-19, but it remains unclear for how long the protection remains. Serology testing seems to have a higher sensitivity than molecular diagnostics from 8 days after onset of symtoms, and should be part of risk assessment and epidemiological studies of COVID-19. The performance of commercial serological point-of-care (POC) lateral flow tests are highly manufacturer-dependant. Low sensitivity increases the risk of false negative results and could result in unnecessary quarantine of test persons with developed antibodies. Low specificity increases the risk of false positive results and could lead to false assumptions of immunity. Carefully selected serological POC tests for sars-cov-2 can be used in large scale testing but should only be used by licensed medical staff able to understand their limitations and interpret the results. |*Betacoronavirus/immunology[MESH] |*Clinical Laboratory Techniques/standards[MESH] |*Coronavirus Infections/diagnosis/immunology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/diagnosis/immunology[MESH] |*Point-of-Care Systems/standards[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Epidemiologic Studies[MESH] |Humans[MESH] |SARS-CoV-2[MESH] |Sensitivity and Specificity[MESH]Snabbtest for covid-19-antikroppar bor utforas av utbildad personal (epmc).pdf DeepDyve Pubget Overpricing